Han K, Wannamaker P, Lu H, Zhu B, et al. Safety, Tolerability, Pharmacokinetics, and Acceptability of Oral and Long-Acting Cabotegravir in HIV-Negative Chinese Men. Antimicrob Agents Chemother 2022 Feb 7:AAC0205721. doi: 10.1128/AAC.02057.
PMID: 35129374